Rural-Urban Disparities in Health Access Factors Over Time: Implications for Cancer Prevention and Health Equity in the Midwest.

cancer health equity population level rural socioeconomic factors

Journal

Health equity
ISSN: 2473-1242
Titre abrégé: Health Equity
Pays: United States
ID NLM: 101708316

Informations de publication

Date de publication:
2022
Historique:
accepted: 12 04 2022
entrez: 2 6 2022
pubmed: 3 6 2022
medline: 3 6 2022
Statut: epublish

Résumé

Population-level environmental and socioeconomic factors may influence cancer burden within communities, particularly in rural and urban areas that may be differentially impacted by factors related to health care access. The University of Kansas (KU) Cancer Center serves a geographically large diverse region with 75% of its 123 counties classified as rural. Using County Health Rankings data and joinpoint regression, we examined trends in four factors related to the socioeconomic environment and health care access from 2009 to 2017 in rural and urban counties across the KU Cancer Center catchment area. The adult health uninsurance rate declined significantly in rural and urban counties across the catchment area (rural annual percent change [APC]=-5.96; 95% CI=[-7.71 to -4.17]; urban APC=-5.72; 95% CI=[-8.03 to -3.35]). Childhood poverty significantly decreased in rural counties over time (APC=-2.94; 95% CI=[-4.52 to -1.33]); in contrast, urban childhood poverty rates did not significantly change before 2012 (APC=3.68; 95% CI=[-15.12 to 26.65]), after which rates declined (APC=-5.89; 95% CI=[-10.01 to -1.58]). The number of primary care providers increased slightly but significantly in both rural and urban counties (APC=0.54; 95% CI=[0.28 to 0.80]), although urban counties had more primary care providers than rural areas (76.1 per 100K population vs. 57.1 per 100K population, respectively; Our findings reveal potential disparities in systemic factors that may contribute to differences in cancer prevention, care, and survivorship in rural and urban regions.

Identifiants

pubmed: 35651355
doi: 10.1089/heq.2021.0068
pii: 10.1089/heq.2021.0068
pmc: PMC9148661
doi:

Types de publication

Journal Article

Langues

eng

Pagination

382-389

Subventions

Organisme : NIGMS NIH HHS
ID : P20 GM130423
Pays : United States

Informations de copyright

© Jordan Baker et al., 2022; Published by Mary Ann Liebert, Inc.

Déclaration de conflit d'intérêts

No competing financial interests exist.

Références

Prev Med. 2017 Nov;104:79-85
pubmed: 28315761
Oncology (Williston Park). 2015 Sep;29(9):633-40
pubmed: 26384798
J Rural Health. 2018 Feb;34 Suppl 1:s3-s12
pubmed: 27677973
MMWR Surveill Summ. 2017 Jul 07;66(14):1-13
pubmed: 28683054
Database (Oxford). 2020 Jan 1;2020:
pubmed: 32719846
J Cancer. 2015 Jun 24;6(8):727-33
pubmed: 26185534
J Rural Health. 2016 Spring;32(2):196-203
pubmed: 26376210
Ann Am Thorac Soc. 2017 Mar;14(3):403-411
pubmed: 28118039
JAMA Intern Med. 2019 Apr 1;179(4):506-514
pubmed: 30776056
Lancet. 2016 Aug 13;388(10045):684-95
pubmed: 27236345
J Rural Health. 2015 Fall;31(4):392-400
pubmed: 25951881
Health Serv Res. 2018 Apr;53(2):1248-1271
pubmed: 28517042
Public Health. 2015 Jun;129(6):611-20
pubmed: 26025176
Health Aff (Millwood). 2018 Jun;37(6):944-950
pubmed: 29863941
Health Aff (Millwood). 2018 Apr;37(4):591-599
pubmed: 29608372
Health Aff (Millwood). 2019 Dec;38(12):2041-2047
pubmed: 31794303
Ann Fam Med. 2019 Nov;17(6):526-537
pubmed: 31712291
Am J Clin Oncol. 2019 Mar;42(3):298-303
pubmed: 30663997
Cancer. 2015 Apr 15;121(8):1279-86
pubmed: 25492559
Cancer Epidemiol Biomarkers Prev. 2018 Nov;27(11):1265-1274
pubmed: 28751476
JCO Oncol Pract. 2020 Jul;16(7):422-430
pubmed: 32574128
PLoS One. 2017 Mar 8;12(3):e0173370
pubmed: 28273125
Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):992-997
pubmed: 28600296
BMC Public Health. 2021 Nov 24;21(1):2154
pubmed: 34819024

Auteurs

Jordan Baker (J)

Department of Biostatistics & Data Science, School of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.

Hope Krebill (H)

University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, Kansas, USA.
Masonic Cancer Alliance, Fairway, Kansas, USA.

Hanluen Kuo (H)

University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, Kansas, USA.
Masonic Cancer Alliance, Fairway, Kansas, USA.

Ronald C Chen (RC)

University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, Kansas, USA.
Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, Kansas, USA.

Jeffrey A Thompson (JA)

Department of Biostatistics & Data Science, School of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, Kansas, USA.

Matthew S Mayo (MS)

Department of Biostatistics & Data Science, School of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, Kansas, USA.

Dinesh Pal Mudaranthakam (DP)

Department of Biostatistics & Data Science, School of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, Kansas, USA.

Lynn Chollet-Hinton (L)

Department of Biostatistics & Data Science, School of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, Kansas, USA.

Classifications MeSH